Hamilton-Miller JM (November 2003). “Chemical and microbiologic aspects of penems, a distinct class of beta-lactams: focus on faropenem”. 《Pharmacotherapy》 23 (11): 1497–1507. doi:10.1592/phco.23.14.1497.31937. PMID14620395. S2CID43705118.
Vitaku E, Smith DT, Njardarson JT (December 2014). “Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals”. 《Journal of Medicinal Chemistry》 57 (24): 10257–10274. doi:10.1021/jm501100b. PMID25255204.
Molteni E, Onida G, Ceccarelli M, Cappellini G (2021년 4월 3일). “Ab Initio Spectroscopic Investigation of Pharmacologically Relevant Chiral Molecules: The Cases of Avibactam, Cephems, and Idelalisib as Benchmarks for Antibiotics and Anticancer Drugs”. 《Symmetry》 (영어) 13 (4): 601. Bibcode:2021Symm...13..601M. doi:10.3390/sym13040601. ISSN2073-8994.
harvard.edu
adsabs.harvard.edu
Molteni E, Onida G, Ceccarelli M, Cappellini G (2021년 4월 3일). “Ab Initio Spectroscopic Investigation of Pharmacologically Relevant Chiral Molecules: The Cases of Avibactam, Cephems, and Idelalisib as Benchmarks for Antibiotics and Anticancer Drugs”. 《Symmetry》 (영어) 13 (4): 601. Bibcode:2021Symm...13..601M. doi:10.3390/sym13040601. ISSN2073-8994.
nih.gov
ncbi.nlm.nih.gov
Hamilton-Miller JM (November 2003). “Chemical and microbiologic aspects of penems, a distinct class of beta-lactams: focus on faropenem”. 《Pharmacotherapy》 23 (11): 1497–1507. doi:10.1592/phco.23.14.1497.31937. PMID14620395. S2CID43705118.
Vitaku E, Smith DT, Njardarson JT (December 2014). “Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals”. 《Journal of Medicinal Chemistry》 57 (24): 10257–10274. doi:10.1021/jm501100b. PMID25255204.
Hamilton-Miller JM (November 2003). “Chemical and microbiologic aspects of penems, a distinct class of beta-lactams: focus on faropenem”. 《Pharmacotherapy》 23 (11): 1497–1507. doi:10.1592/phco.23.14.1497.31937. PMID14620395. S2CID43705118.
worldcat.org
Molteni E, Onida G, Ceccarelli M, Cappellini G (2021년 4월 3일). “Ab Initio Spectroscopic Investigation of Pharmacologically Relevant Chiral Molecules: The Cases of Avibactam, Cephems, and Idelalisib as Benchmarks for Antibiotics and Anticancer Drugs”. 《Symmetry》 (영어) 13 (4): 601. Bibcode:2021Symm...13..601M. doi:10.3390/sym13040601. ISSN2073-8994.